Naunyn-Schmiedeberg's Archives of Pharmacology

, Volume 345, Issue 1, pp 64–70 | Cite as

Comparison of a cloned ANF-sensitive guanylate cyclase (GC-A) with particulate guanylate cyclase from adrenal cortex

  • Jörg-Martin Heim
  • Sujay Singh
  • Hans-Jürgen Fülle
  • Rupert Gerzer


Recently, an ANF-sensitive guanylate cyclase (GC-A) has been cloned from a rat brain cDNA library. Here we studied the stimulation of cyclic GMP accumulation in response to atrial natriuretic factor (ANF), urodilatin and atriopeptin I (AP-1) in a rat glioma C6 cell line permanently transfected with GC-A as well as GC-A activity in membranes from these C6 cells and in membranes from COS-7 cells that were transiently transfected with GC-A. We also measured binding affinities for these natriuretic peptides in the membrane preparations. These characteristics of GC-A were compared to those of membrane preparations from adrenal cortex of bovine and human origin. The order of potency of stimulation of cyclic GMP accumulation in permanently transfected glioma cells was ANF > urodilatin > AP I; AP I stimulated cyclic GMP accumulation. A similar order of potency was obtained for stimulation of guanylate cyclase activity in membranes from permanently transfected glioma cells as well as from transiently transfected COS-7 cells. In contrast, AP-1 was uneffective to stimulate guanylate cyclase in membrane preparations from adrenal cortex from bovine as well as from human origin. Furthermore, urodilatin was equipotent to ANF in these preparations. Binding affinities were comparable for ANF and urodilatin in membranes from cells transfected with GC-A and in membranes from adrenal cortex of both sources, whereas AP-1 had a weaker affinity in all preparations studied.

These results suggest that GC-A is different from ANF-sensitive guanylate cyclase from bovine and human adrenal cortex and that these cyclases can be distinguished by the ability of AP-1 as well as urodilatin to stimulate guanylate cyclase activity. Since binding characteristics for the studied peptides were comparable, the signal transduction mechanisms rather than binding characteristics may be different in ANF-sensitive guanylate cyclase from adrenal cortex and in GC-A.

Key words

Particulate guanylate cyclase Atrial natriuretic peptides Cyclic GMP Urodilatin 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. de Bold AJ, Borenstein HB, Veress AT, Sonnenberg H (1981) A rapid and potent response to intravenous injection of atrial myocardial extracts in rats. Life Sci 28:89–94Google Scholar
  2. Chang M, Lowe DG, Lewis M, Hellmiss R, Chen E, Goeddell DV (1989) Differential activation by atrial and brain natriuretic peptides of two different receptor guanylate cyclases. Nature 341:68–72Google Scholar
  3. Chinkers M, Garbers DL (1989) The protein kinase domain of the ANP receptor is required for signaling. Science 245:1392–1394Google Scholar
  4. Chinkers M, Garbers DL, Chang MS, Lowe DG, Chin H, Goeddel DV, Schulz S (1989) A membrane form of guanylate cyclase is an atrial natriuretic peptide receptor. Nature 338:78–83Google Scholar
  5. Cullen BR (1987) Use of eukaryotic expression technology in the functional analysis of cloned genes. Methods Enzymol 152:684–687Google Scholar
  6. De Lean A, Gutkowska J, McNicoll N, Schiller PW Cantin M, Genest J (1984) Characterization of specific receptors for atrial natriuretic factor in bovine adrenal zona glomerulosa. Life Sci 35:2311–2318Google Scholar
  7. Felgner PL, Gadek TR, Holm M, Roman R, Chen HW, Wenz H, Northrop JF, Ringold GM, Danielsen M (1987) Lipofectin: A highly efficient, lipid-mediated DNA-transduction procedure. Proc Natl Acad Sci USA 84:7413–7417Google Scholar
  8. Feller SM, Gagelmann M, Forssmann WG (1989) Urodilatin: a newly described member of the ANP family. Trends Pharmacol Sci 10:93–94Google Scholar
  9. Fülle H-J, Heim J-M, Gerzer R (1991) Functional modulation of ANF-sensitive guanylate cyclase by redox mechanisms. Eur J Pharmacol (Mol Pharmacol Sect) 206:69–75Google Scholar
  10. Fuller F, Porter JG, Arfsten A, Miller J, Schilling JW, Scarborough RM, Lewicki JA, Schenk DB (1988) Atrial natriuretic clearance receptor. J Biol Chem 263:9595–9401Google Scholar
  11. Heim J-M, Ivanova K, Gerzer R (1988) Amiloride increases the sensitivity of particulate guanylate cyclase to atrial natriuretic factor. Biochem Biophys Res Commun 152:1263–1268Google Scholar
  12. Heim J-M, Kiefersauer S, Fülle H-J, Gerzer R (1989) Urodilatin and \-ANF: Binding properties and activation of particulate guanylate cyclase. Biochem Biophys Res Commun 163:37–41Google Scholar
  13. Hintze TH, Currie MG, Needleman P (1985) Atriopeptins: renal-specific vasodilators in conscious dogs. Am J Physiol 248:H587-H591Google Scholar
  14. Holleman WH, Bush EN, Devine EM, Firestone SL, Rockway TW, Sarin VK, Budzik GP (1988) Atrial natriuretic factor: structural requirements of the peptide for receptor binding, biological activity, and cGMP stimulation. Drug Developm Res 12:109–117Google Scholar
  15. Inagami T (1989) Atrial natriuretic factor. J Biol Chem 264:3043–3046Google Scholar
  16. Ivanova K, Heim J-M, Gerzer R (1990) Kinetic characterization of atrial natriuretic factor-sensitive particulate guanylate cyclase. Eur J Pharmacol (Mol Pharmacol Sect) 189:317–326Google Scholar
  17. Kentsch M, Ludwig D, Gerzer R, Müller-Esch E (1990) Hämodynamische und diuretische Effekte von Urodilatin (95–126-ANF) bei Probanden. Z Kardiol 79 [Suppl 1]:158Google Scholar
  18. Koesling D, Harteneck C, Humbert P, Bosserhof A, Frank R, Schultz G, Böhme E (1990) FEBS Lett 266:128–132Google Scholar
  19. Kuno T, Andresen JW, Kamisaki Y, Waldman SA, Chang LY, Saheki S, Leitman DC, Nakane M, Murad F (1986) Co-purification of an atrial natriuretic factor receptor and particulate guanylate cyclase from rat lung. J Biol Chem 261:5817–5823Google Scholar
  20. Leitman DC, Andresen JW, Kuno T, Kamisaki Y, Chang JK, Murad F (1986) Identification of multiple binding sites for atrial natriuretic factor by affinity cross-linking in cultured endothelial cells. J Biol Chem 261:11650–11655Google Scholar
  21. Leitman DC, Andresen JW, Catalano RM, Waldman SA, Tuan JJ, Murad F (1988) Atrial natriuretic peptide binding, cross-linking, and stimulation of cyclic GMP accumulation and particulate guanylate cyclase activity in cultured cells. J Biol Chem 263:3720–3728Google Scholar
  22. Lowe DG, Chang MS, Hellmiss R, Chen E, Singh S, Garbers DL, Goeddel DV (1989) Human atrial natriuretic peptide receptor defines a new paradigm for second messenger signal transduction. EMBO J 8:1377–1384Google Scholar
  23. Lowry DH, Roseborough NJ, Farr AL, Randall RJ (1951) Protein measurement with the Folin Phenol Reagent. J Biol Chem 193:265–275PubMedGoogle Scholar
  24. Maack T, Suzuki M, Almeida FA, Nussenzveig D, Scarborough RM, McEnroe GA, Lewicki JA (1987) Physiological role of silent receptors of atrial natriuretic factor. Science 238:675–678Google Scholar
  25. Meloche S, McNicoll N, Liu B, Ong H, De Lean A (1988) Atrial natriuretic factor R1 receptor from bovine adrenal zona glomerulosa: purification, characterization, and modulation by amiloride. Biochemistry 27:8151–8158Google Scholar
  26. Mizuno T, Katafuchi T, Hagiwara H, Ito T, Kangawa K, Matsuo H, Hirose S (1990) Human adrenal tumor cell line SW-13 contains a natriuretic peptide receptor system that responds preferentially to ANP among various natriuretic peptides. Biochem Biophys Res Commun 173:886–893Google Scholar
  27. Nakane M, Ara K, Saheki S, Kuno T, Buechler W, Murad F (1990) Molecular cloning and expression of cDNAs coding for soluble guanylate cyclase from rat lung. J Biol Chem 265: 16841–16845Google Scholar
  28. Needleman P, Blaine EH, Greenwald JE, Michener ML, Saper CB, Stockmann PT, Tolunay HE (1989) The biochemical pharmacology of atrial peptides. Annu Rev Pharmacol Toxicol 29:23–54Google Scholar
  29. Nussenzveig DR, Lewicki JA, Maack T (1990) Cellular mechanisms of the clearance function of type C receptors of atrial natriuretic factor. J Biol Chem 265:20952–20958Google Scholar
  30. Paul AK, Marala RB, Jaiswal RK, Sharma RK (1987) Coexistence of guanylate cyclase and atrial natriuretic factor receptor in a 180-kD protein. Science 235:1224–1226Google Scholar
  31. Peterson GL (1977) A simplification of the protein assay method of Lowry et al. which is more generally applicable. Anal Biochem 83:357–363Google Scholar
  32. Saxenhofer H, Raselli A, Weidmann P, Forssmann WG, Bub A, Ferrari P, Shaw SG (1990) Urodilatin, a natriuretic factor from kidneys, can modify renal and cardiovascular function in man. Am J Physiol 259:F832-F838Google Scholar
  33. Schulz S, Singh S, Bellet RA, Singh G, Tubb DJ, Chin H, Garbers DL (1989) The primary structure of a plasma membrane guanylate cyclase demonstrates diversity within this new receptor family. Cell 58:1155–1162Google Scholar
  34. Schulz-Knappe P, Forssmann K, Herbst F, Hock D, Pipkorn R, Forssmann WG (1988) Isolation and structural analysis of “Urodilatin” a new peptide of the cardiodilatin-(ANP)-family, extracted from human urine. Klin Wochenschr 66:752–759Google Scholar
  35. Takayanagi R, Snajdar RM, Imada T, Tamura M, Pandey KN, Misono KS, Inagami T (1987) Purification and characterization of two types of atrial natriuretic factor receptors from bovine adrenal cortex: guanylate cyclase-linked and cyclase-free receptors. Biochem Biophys Res Commun 144:244–250Google Scholar
  36. Wakitani K, Oshima T, Loewy AD, Holmberg SW, Cole BR, Adams SP, Fok KF, Currie MG, Needleman P (1985) Comparative vascular pharmacology of the atriopeptins. Circ Res 56:621–627Google Scholar

Copyright information

© Springer-Verlag 1992

Authors and Affiliations

  • Jörg-Martin Heim
    • 1
  • Sujay Singh
    • 1
  • Hans-Jürgen Fülle
    • 1
  • Rupert Gerzer
    • 1
  1. 1.Labor für klinische PharmakologieMedizinische Klinik, Klinikum Innnenstadt der UniversitätMünchen 2Federal Republic of Germany

Personalised recommendations